Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2013Molecular OncologyOpen Access

Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation

View Full Paper
Ask AI
Bookmark
Share

Authors

HKHyeong Ryul KimUniversity of UlsanWKWoo Sung KimNorthside HospitalYCYun Jung ChoiThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kim et al. (2013) studied this question.

synapsesocial.com/papers/69d89acf18b0ca7f91d186c1https://doi.org/10.1016/j.molonc.2013.08.001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients2005 · 494 citations
  2. 2Inhibition of Hsp90 Down-regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel2008 · 180 citations
  3. 3TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)2005 · 754 citations
  4. 4Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma1994 · 2,425 citations
  5. 5A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors2011 · 606 citations